CMD stock forecast
Our latest prediction for Cantel Medical Corp.'s stock price was made on the Oct. 23, 2019 when the stock price was at 70.98$.
In the short term (2weeks), CMD's stock price should outperform the market by 0.18%. During that period the price should oscillate between -4.47% and +5.42%.
In the medium term (3months), CMD's stock price should outperform the market by 0.92%. During that period the price should oscillate between -11.19% and +14.47%.Get email alerts
About Cantel Medical Corp.
Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. It operates through the following business segments: Medical, Life Sciences, Dental and Dialysis. The Medical segment designs, develops, manufactures, sells and installs a comprehensive offering of products and services comprising a complete circle of infection prevention solutions. The Life Sciences segment designs, develops, manufactures, sells and installs water purification systems for medical, pharmaceutical and other bacteria controlled applications. The Dental segment designs, manufactures, sells, supplies and distributes a broad selection of infection prevention healthcare products, the majority of which are single-use products used by dental practitioners. The Dialysis segment designs, develops, manufactures, sells and services reprocessing systems and sterilants for dialyzers as well as dialysate concentrates and supplies utilized for renal dialysis. Cantel Medical was founded on August 16, 1963 and is headquartered in Little Falls, NJ.
At the moment the company generates 950M USD in revenues.
On its last earning announcement, the company reported a profit of 1.00$ per share.
The book value per share is 14.42$
Three months stock forecastOct. 23, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|